Euclidean Technologies Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$221K Hold
2,740
0.2% 64
2022
Q4
$205K Buy
+2,740
New +$195K 0.2% 63
2022
Q2
Sell
-2,740
Closed -$210K 77
2022
Q1
$210K Hold
2,740
0.19% 75
2021
Q4
$210K Hold
2,740
0.18% 84
2021
Q3
$202K Buy
+2,740
New +$205K 0.18% 78

Other funds holding HOLX

Euclidean Technologies Management's HOLX Position: Q1 2023 in Review

Euclidean Technologies Management held its Hologic (HOLX) position steady in Q1 2023 at 2,740 shares worth $221K. The position accounts for 0.2% of the portfolio, ranked #64.

Euclidean Technologies Management first reported a position in HOLX in Q3 2021 and has held it in 5 quarters since. 707 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Euclidean Technologies Management held 2,740 shares of Hologic worth $221K as of Q1 2023.
  • Euclidean Technologies Management left its Hologic share count unchanged in Q1 2023.
  • Hologic made up 0.2% of Euclidean Technologies Management's portfolio in Q1 2023, its #64 holding.
  • Euclidean Technologies Management first reported a position in Hologic in Q3 2021 and has held it in 5 quarters since.
  • 707 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Euclidean Technologies Management's 13F filing for Q1 2023, filed 26 Apr 2023.